相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
Ki-67
- 级别:
mouse/human Ki-67 Antibody
- 目录编号:
mouse/human Ki-67 Antibody
- 克隆性:
单克隆
- 抗原来源:
大鼠
- 保质期:
mouse/human Ki-67 Antibody
- 抗体英文名:
anti-mouse/human Ki-67 Antibody-FITC
- 抗体名:
mouse/human Ki-67 Antibody
- 标记物:
FITC
- 宿主:
大鼠
- 适应物种:
人、小鼠
- 免疫原:
mouse/human Ki-67 Antibody
- 亚型:
mouse/human Ki-67 Antibody
- 形态:
mouse/human Ki-67 Antibody
- 应用范围:
ICFC
- 保存条件:
2-8℃
- 浓度:
0.5 mg/ml
- 规格:
25 µg/100 µg
| 规格: | 25 µg | 产品价格: | ¥2300.0 |
|---|---|---|---|
| 规格: | 100 µg | 产品价格: | ¥5700.0 |
anti-mouse/human Ki-67 Antibody-FITC详细如下:
Description :The nuclear protein Ki-67 was first identified by the monoclonal antibody Ki-67, which wasgenerated by immunizing mice with nuclei of the L428 Hodgkin lymphoma cell line. Ki-67 proteinplays an essential role in ribosomal RNA transcription and cell proliferation. Expression of Ki-67occurs during G1, S, G2, and M phase. While in G0 phase, the Ki-67 protein is not detectable.Ki-67 is strongly expressed in proliferating cells and has been reported as a prognostic markerin various tumors.
Verified Reactivity :Mouse, Human
Antibody Type :Monoclonal
Host Species :Rat
Immunogen :E. coli expressed, N-terminal His-Thioredoxin-tagged, partial mKi-67 (1816-2163 aa) recombinantprotein.
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography and conjugated with FITC under optimalconditions.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :ICFC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by intracellular immunofluorescent staining withflow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µgper million cells in 100 µl volume. It is recommended that the reagent be titrated for optimalperformance for each application.
Excitation Laser :Blue Laser (488 nm)
Description :The nuclear protein Ki-67 was first identified by the monoclonal antibody Ki-67, which wasgenerated by immunizing mice with nuclei of the L428 Hodgkin lymphoma cell line. Ki-67 proteinplays an essential role in ribosomal RNA transcription and cell proliferation. Expression of Ki-67occurs during G1, S, G2, and M phase. While in G0 phase, the Ki-67 protein is not detectable.Ki-67 is strongly expressed in proliferating cells and has been reported as a prognostic markerin various tumors.
Verified Reactivity :Mouse, Human
Antibody Type :Monoclonal
Host Species :Rat
Immunogen :E. coli expressed, N-terminal His-Thioredoxin-tagged, partial mKi-67 (1816-2163 aa) recombinantprotein.
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography and conjugated with FITC under optimalconditions.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :ICFC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by intracellular immunofluorescent staining withflow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µgper million cells in 100 µl volume. It is recommended that the reagent be titrated for optimalperformance for each application.
Excitation Laser :Blue Laser (488 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Product Citations:
1. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
2. Zhou WJ, et al. 2021. Theranostics. 11:5330. PubMed
3. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
4. Silconi ZB, et al. 2022. Int J Mol Sci. 23:. PubMed
5. Yang R, et al. 2020. Cell. 183(7):1826-1847.e31. PubMed
6. Yamada D, et al. 2022. Front Immunol. 13:1025499. PubMed
7. Su X, et al. 2022. J Transl Med. 20:378. PubMed
8. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
9. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
1. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
2. Zhou WJ, et al. 2021. Theranostics. 11:5330. PubMed
3. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
4. Silconi ZB, et al. 2022. Int J Mol Sci. 23:. PubMed
5. Yang R, et al. 2020. Cell. 183(7):1826-1847.e31. PubMed
6. Yamada D, et al. 2022. Front Immunol. 13:1025499. PubMed
7. Su X, et al. 2022. J Transl Med. 20:378. PubMed
8. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
9. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
文献支持
抗小鼠/人 Ki-67 荧光标记FITC 抗体
¥2300 - 5700










